RVTY
$87.37
Revvity, Inc.
Recent News
Emerald Growth Equity Strategy Sold Revvity (RVTY) in Q4
Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q4 2025 investor letter for the “Growth Equity Strategy.” A copy of the letter is available to download here. In 2025, the strategy returned +3.1% (gross) and +3.0% (net), resulting in the year-to-date return of 16.7% (gross) and +16.0% (net). […]
How The Revvity (RVTY) Narrative Is Shifting With Higher Targets And Tempered Growth Assumptions
Revvity’s fair value estimate has been revised from US$114.63 to US$119.56, a modest uplift that puts fresh attention on where analysts think the stock should trade. That shift lines up with bullish commentary pointing to recovering end markets, early improvement in China and healthier survey data on procedures and CapEx, even as expectations for growth and margins are more restrained. As you read on, you will see how this evolving narrative might shape the way you track Revvity from...
Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
Bretton Fund Exited Revvity (RVTY) in 2025
Bretton Capital Management, an investment management company, released the “Bretton Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Bretton Fund returned 1.44% in Q4 2025 compared to 2.66% for the S&P 500 Index. In 2025, the Fund returned 11.58% compared to 17.88% for the Index. Although the market fluctuates daily […]
Why Is Revvity (RVTY) Down 5.1% Since Last Earnings Report?
Revvity (RVTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.